REQUEST A DEMO
Total
USD $0.00
Search more companies

A B Roys Pharmaceuticals Private Limited (India)

Main Activities: Other Business Support Services
Full name: A B Roys Pharmaceuticals Private Limited Profile Updated: March 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

A B Roys Pharmaceuticals Private Limited is based in India. The head office is in Kolkata. It operates in the Other Business Support Services sector. A B Roys Pharmaceuticals Private Limited was incorporated on February 20, 1998. In 2025, the company reported a net sales revenue increase of 11.07%. Its’ total assets recorded a negative growth of 12.45%. The net profit margin of A B Roys Pharmaceuticals Private Limited increased by 0.15% in 2025.

Legal Address
2 South Roadsantoshpur
Kolkata; West Bengal; Postal Code: 700075

Contact Details: Purchase the A B Roys Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the A B Roys Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the A B Roys Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
February 20, 1998
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after A B Roys Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
11.07%
Total Operating Revenue
11.07%
Operating Profit
4.61%
EBITDA
5.56%
Net Profit/Loss for the Period
50.72%
Total Assets
-12.45%
Total Equity
6.79%
Operating Profit Margin
-0.06%
Net Profit Margin
0.15%
Return on Equity (ROE)
1.74%
Debt / Equity
-25%
Quick Ratio
0.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?